First product based on LTS Sorrel™ wearable drug delivery platform launched in the US

Contributed by: PR Newswire

Tags

LTS-Sorrel-US

More Like This

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories

PR Newswire associated0

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation

OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science

PR Newswire associated0

Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform